Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct continuous ketamine infusion in mechanically ventilated ICU patients
ISRCTN14730035Phase 3Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ketamine (2 arms), sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Duration of mechanical ventilation. Started Sep 2019; status: completed.
02
Drugs
ketamine
Beyond the preview
Go deeper on ISRCTN14730035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14730035.